{"disease":{"id":"enthesitis-related-arthritis-juvenile","name":"enthesitis related arthritis juvenile"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06668181","title":"An Open-label Study to Evaluate the Pharmacokinetics and Safety of Bimekizumab in Pediatric Study Participants With Active Juvenile Idiopathic Arthritis Subtypes Enthesitis-related Arthritis (Including Juvenile-onset Ankylosing Spondylitis) and Juvenile Psoriatic Arthritis","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"UCB Biopharma SRL","has_results":false},{"nct_id":"NCT06383195","title":"The Reliability and Validity of the Ankylosing Spondylitis Performance Index (ASPI) in Enthesitis-Related Arthritis","phase":"","overall_status":"RECRUITING","enrollment_count":40,"lead_sponsor_name":"Hacettepe University","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}